ROYAL BANK of CANADA

RBC’s $500 m brokerage deal with NSR sparks questions on Canadian banks’ influence in Aussie resource finance, exploring conflicts, market impact, and shareholder value.

RBC’s shift from TCS to Accenture boosts cloud‑native AI, rebadges 150 staff and cuts costs while strengthening capital‑raising and regulatory compliance for long‑term growth.

RBC’s Q1 2026 earnings rise modestly while new equity‑linked contingent‑yield notes offer downside protection and upside potential for institutional fixed‑income investors, amid tighter rates and growing corporate action services.

RBC’s new Swiss Market Index‑linked securities and DCC stake reveal a strategy to boost capital, diversify exposure, and sharpen governance—key insights for investors.

RBC’s new floating‑rate and Boston Scientific‑linked notes reveal hidden concentration risk, cross‑border regulatory concerns, and powerful institutional influence—questioning the bank’s true capital‑raising strategy.

RBC’s dual strategy—buying back Northern Star shares while selling Moneris—showcases a bold blend of mining exposure and fintech evolution, reshaping Canada’s banking landscape.

RBC launches an Indigenous Enterprise Advisory Unit to close the 3.7% credit gap, offering tailored loans, ESG transparency and a $1.5 billion growth opportunity.

RBC’s latest prospectuses reveal a strategic push to bolster capital, focus on fee‑based private‑banking and wealth management, and streamline operations—positioning the bank for resilient growth amid tightening regulation and market volatility.

RBC’s diversified retail, wealth‑management, and capital‑market model earns analyst upgrades & higher price targets—showing why investors view it as a resilient, growth‑oriented bank.

RBC’s early‑April 2026 research notes reveal cautious, conservative price upgrades across healthcare, energy, and tech, but leave key assumptions and social impacts largely unexplored.